OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
QEM54

QEM Ltd

UraniumVerified

QEM Ltd operates with a fully diluted share count of 296,500,353 shares, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options or convertible securities. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability and returns data are not available for QEM Ltd, as the valuation snapshot is currently computed as unknown. This lack of data prevents a direct comparison to industry_config preferred metrics or cohort medians for the Uranium industry. The company's revenue concentration and geographic exposure are not disclosed in the available data. As a uranium producer in the Northern Territory, QEM Ltd is likely concentrated in the Australian market, but no specific segment or geographic revenue breakdown is available for analysis. Growth trajectory data is also unavailable, as the outlook for the current and next fiscal years is not provided. Without revenue history or forward-looking guidance, it is not possible to assess the company's growth potential or trajectory. Risk factors for QEM Ltd include the inability to assess liquidity risk, as noted in the risk assessment. Additionally, the company's exposure to uranium market volatility and regulatory changes in the mining sector are not quantified in the available data. Recent events, including filings and transcripts, are not disclosed in the available data. The absence of recent financial or operational disclosures limits the ability to assess the company's current strategic direction or operational performance.

30-day price · QEM-0.00 (-2.4%)
Low$0.04High$0.06Close$0.04As of12 May, 00:00 UTC
Profile
CompanyQEM Ltd
TickerQEM.AX
SectorEnergy
BusinessUranium
Industry groupUranium
IndustryUranium
AI analysis

Business. QEM Ltd is an Australian uranium producer focused on the exploration, development, and production of uranium resources in the Alligator Rivers Uranium Province of the Northern Territory.

Classification. QEM Ltd is classified under the Energy economic sector, Uranium business sector, and Uranium industry with a confidence level of 0.92 based on verified market data.

QEM Ltd operates with a fully diluted share count of 296,500,353 shares, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options or convertible securities. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability and returns data are not available for QEM Ltd, as the valuation snapshot is currently computed as unknown. This lack of data prevents a direct comparison to industry_config preferred metrics or cohort medians for the Uranium industry. The company's revenue concentration and geographic exposure are not disclosed in the available data. As a uranium producer in the Northern Territory, QEM Ltd is likely concentrated in the Australian market, but no specific segment or geographic revenue breakdown is available for analysis. Growth trajectory data is also unavailable, as the outlook for the current and next fiscal years is not provided. Without revenue history or forward-looking guidance, it is not possible to assess the company's growth potential or trajectory. Risk factors for QEM Ltd include the inability to assess liquidity risk, as noted in the risk assessment. Additionally, the company's exposure to uranium market volatility and regulatory changes in the mining sector are not quantified in the available data. Recent events, including filings and transcripts, are not disclosed in the available data. The absence of recent financial or operational disclosures limits the ability to assess the company's current strategic direction or operational performance.
Key takeaways
  • QEM Ltd has no dilution risk as basic and diluted shares are equal.
  • Liquidity risk could not be assessed due to missing balance-sheet data.
  • No profitability or returns data is available for comparison to industry benchmarks.
  • Revenue concentration and geographic exposure are not disclosed in the available data.
  • Growth trajectory and outlook data are unavailable, limiting forward-looking analysis.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyAUD
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$339.3k-$1.4M-$1.4M-$1.3M
FY-3$256.8k-$2.8M-$2.8M-$3.4M
FY-2$12.9k-$5.0M-$4.6M-$4.9M
FY-1$14.8k-$4.9M-$2.0M-$1.8M
FY0$19.6k-$3.5M-$3.2M-$3.1M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$1.4M$1.1M
FY-3$2.6M$1.8M
FY-2$3.4M$2.7M
FY-1$2.3M$1.6M
FY0$3.4M$2.8M
PeriodOCFCapExFCFSBC
FY-4-$1.2M-$1.3M
FY-3-$2.7M-$684.5k-$3.4M
FY-2-$3.5M-$608.7k-$4.9M
FY-1-$4.0M-$35.8k-$1.8M
FY0-$2.9M-$13.5k-$3.1M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Uranium · cohort 14 companies
MetricQEMActivity
Op margin-395.2% medp25 -1558.7% · p75 -29.8%
Net margin-371.3% medp25 -1590.3% · p75 -34.4%
Gross margin-7.9% medp25 -85.3% · p75 1.0%
R&D / revenue3.8% medp25 3.8% · p75 3.8%
CapEx / revenue-29.6% medp25 -532.5% · p75 -10.0%
Debt / equity0.2% medp25 0.0% · p75 7.1%
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-05 02:32 UTC#97fe539a
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 02:58 UTCJob: 0db04077